Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.470
+0.088 (3.69%)
Jan 13, 2026, 4:25 PM CET
Nykode Therapeutics AS Market Cap
Nykode Therapeutics AS has a market cap or net worth of 806.57 million as of January 13, 2026. Its market cap has decreased by -14.47% in one year.
Market Cap
806.57M
Enterprise Value
196.99M
Revenue
73.37M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.47
Market Cap Chart
Since January 28, 2020, Nykode Therapeutics AS's market cap has decreased from 5.52B to 806.57M, a decrease of -85.40%. That is a compound annual growth rate of -27.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 806.57M | 2.40% |
| Dec 30, 2025 | 787.63M | -20.81% |
| Dec 30, 2024 | 994.66M | -85.77% |
| Dec 29, 2023 | 6.99B | -15.67% |
| Dec 30, 2022 | 8.29B | -64.54% |
| Dec 30, 2021 | 23.37B | 9.44% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.55B |
| Nordhealth AS | 2.77B |
| Photocure ASA | 2.06B |
| Thor Medical ASA | 1.81B |
| ArcticZymes Technologies ASA | 1.18B |
| Omda AS | 963.86M |
| Vistin Pharma ASA | 922.37M |
| Gentian Diagnostics ASA | 885.24M |